SCHEMBL863300

SCHEMBL863300

O=S(O)(=S)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
MMP1 P03956 1/20 0.59
MMP2 P08253 1/20 0.59
MMP9 P14780 1/20 0.59
MMP8 P22894 1/20 0.59
MMP13 P45452 1/20 0.59
PRSS1 P07477 2/20 0.54
PRSS2 P07478 2/20 0.54
PRSS3 P35030 2/20 0.54
FAAH O00519 1/20 0.54
ELANE P08246 1/20 0.54
PRTN3 P24158 1/20 0.54
CA5A P35218 1/20 0.54
CA9 Q16790 1/20 0.54
HSP90AA1 P07900 1/20 0.48
F2 P00734 1/20 0.48
KMT2A Q03164 2/20 0.47
TSHR P16473 2/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7905636 0.80 CA2 (0.58) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL30217949 0.80 CA2 (0.58) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL28294303 0.80 CA2 (0.58) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL1749 0.80 CA2 (0.58) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL127384 0.80 CA2 (0.58) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL16034407 0.78 CA2 (0.56) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL1073102 0.78 CA2 (0.56) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL7116 0.78 CA2 (0.56) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL9219268 0.78 CA2 (0.56) CA1CA2MMP1MMP2MMP9
Phenylmethanesulfonic Acid SCHEMBL21811372 0.78 CA2 (0.56) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150646-B2 Surface-oriented antibody coating for the reduction of post-stent restenosis ECONOUS SYSTEMS INC. (CA) 2015-10-06 US claimed
US-20120076833-A1 SURFACE-ORIENTED ANTIBODY COATING FOR THE REDUCTION OF POST-STENT RESTENOSIS ECONOUS SYSTEMS INC. (CA) 2012-03-29 US claimed
CN-117886739-A Preparation method of stable isotope labeled cyproheptadine internal standard reagent 谱同生物医药科技(常州)有限公司 2024-04-16 CN disclosed
US-9150646-B2 Surface-oriented antibody coating for the reduction of post-stent restenosis ECONOUS SYSTEMS INC. (CA) 2015-10-06 US disclosed
US-9150646-B2 Surface-oriented antibody coating for the reduction of post-stent restenosis ECONOUS SYSTEMS INC. (CA) 2015-10-06 US disclosed
EP-2914563-A1 PRESSURE PROCESS WZR Ceramic Solutions GmbH (DE) 2015-09-09 EP disclosed
US-9078956-B2 Modification of biomedical polymers for prevention of fouling and clotting ECONOUS SYSTEMS INC. (CA) 2015-07-14 US disclosed
WO-2014067990-A1 PRESSURE PROCESS WZR ceramic solutions GmbH (DE) 2014-05-08 WO disclosed
US-20140018463-A1 MODIFICATION OF BIOMEDICAL POLYMERS FOR PREVENTION OF FOULING AND CLOTTING ECONOUS SYSTEMS INC. (CA) 2014-01-16 US disclosed
US-8491958-B2 Avoidance of non-specific binding on an acoustic wave biosensor using linker and diluent molecules for device surface modification ECONOUS SYSTEMS INC. (CA) 2013-07-23 US disclosed
US-20120076833-A1 SURFACE-ORIENTED ANTIBODY COATING FOR THE REDUCTION OF POST-STENT RESTENOSIS ECONOUS SYSTEMS INC. (CA) 2012-03-29 US disclosed
US-20120076833-A1 SURFACE-ORIENTED ANTIBODY COATING FOR THE REDUCTION OF POST-STENT RESTENOSIS ECONOUS SYSTEMS INC. (CA) 2012-03-29 US disclosed
US-20110306771-A1 AVOIDANCE OF NON-SPECIFIC BINDING ON AN ACOUSTIC WAVE BIOSENSOR USING LINKER AND DILUENT MOLECULES FOR DEVICE SURFACE MODIFICATION ECONOUS SYSTEMS INC. (CA) 2011-12-15 US disclosed
EP-1036076-A1 NOVEL COMPOUNDS AstraZeneca UK Limited (GB) 2000-09-20 EP disclosed
WO-1999029695-A1 NOVEL COMPOUNDS ASTRAZENECA UK LIMITED (GB) 1999-06-17 WO disclosed
EP-0220129-A2 12- and 13-substituted ergoline derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1987-04-29 EP disclosed